NCEL logo

NCEL
NewcelX Ltd.

6,291
Mkt Cap
$31M
Volume
1.25M
52W High
$47.40
52W Low
$4.20
PE Ratio
-4.20
NCEL Fundamentals
Price
$6.91
Prev Close
$7.62
Open
$5.08
50D MA
$18.71
Beta
0.42
Avg. Volume
88,507.26
EPS (Annual)
-$2.63
P/B
10.74
Rev/Employee
$0.00
Loading...
Loading...
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3

Frequently Asked Questions

What is Market Cap of NewcelX Ltd.?
What is the 52-week high for NewcelX Ltd.?
What is the 52-week low for NewcelX Ltd.?
What is NewcelX Ltd. stock price today?
What was NewcelX Ltd. stock price yesterday?
What is the PE ratio of NewcelX Ltd.?
What is the Price-to-Book ratio of NewcelX Ltd.?
What is the 50-day moving average of NewcelX Ltd.?
How many employess does NewcelX Ltd. has?

Latest NCEL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.